









Markets
/
Stocks
/
nasdaq-aytu
/

Aytu Biopharma Inc

AYTU

View Detailed Chart

2.400USD

0.0000.00%

Close 08/01, 16:00（ET）Quotes delayed by 15 min

14.81MMarket Cap

9.04P/E TTM



Aytu Biopharma Inc

2.400

0.0000.00%

Overview Company Financials

Financials

Intraday

30m

Today

-1.64%

5 Days

-8.57%

1 Month

+0.63%

6 Months

+46.34%

Year to Date

+41.18%

1 Year

-4.76%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 2 analysts

BUY

Current Rating

8.500

Target Price

254.17%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

173

Total

Median

Average

Company name

Ratings

Analysts

Aytu Biopharma Inc

AYTU

Biogen Inc

BIIB

Vertex Pharmaceuticals Inc

VRTX

Alnylam Pharmaceuticals Inc

ALNY

Amgen Inc

AMGN

Gilead Sciences Inc

GILD

...

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

15m

30m

15m

30m

D

Neutral

Sell(5)

Neutral(4)

Buy(3)

Indicators

Sell(2)

Neutral(4)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

-0.044

Neutral

RSI(14)

53.700

Neutral

STOCH(KDJ)(9,3,3)

31.218

Sell

ATR(14)

0.144

High Vlolatility

CCI(14)

-42.434

Neutral

Williams %R

53.333

Neutral

TRIX(12,20)

0.835

Sell

StochRSI(14)

0.000

Oversold

Moving Average

Sell(3)

Neutral(0)

Buy(3)

Indicators

Value

Direction

MA5

2.494

Sell

MA10

2.530

Sell

MA20

2.410

Sell

MA50

2.150

Buy

MA100

1.698

Buy

MA200

1.673

Buy

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Aytu BioPharma, Inc. is a pharmaceutical company focused on commercializing novel therapeutics. The Company's business is focused on its prescription pharmaceutical products sold primarily through third party wholesalers and pharmacies and which primarily consists of two product portfolios. The first consists of two products for the treatment of ADHD: Adzenys XR-ODT (amphetamine) extended-release orally disintegrating tablets (Adzenys) and Cotempla XR-ODT (methylphenidate) extended-release orally disintegrating tablets. The second consists primarily of Karbinal ER (carbinoxamine maleate extended-release oral suspension), an extended-release first-generation antihistamine suspension containing carbinoxamine indicated to treat numerous allergic conditions, and Poly-Vi-Flor and Tri-Vi-Flor, two complementary prescription fluoride-based supplement product lines containing combinations of fluoride and vitamins in various formulations for infants and children with fluoride deficiency.

Ticker SymbolAYTU

CompanyAytu Biopharma Inc

CEOMr. Joshua R. (Josh) Disbrow

Websitehttps://aytubio.com/